United Therapeutics (UTH) Q4 2018 Earnings Report
DE:UTH Q4 2018 EPS Results
- Actual EPS
- EUR 1.32
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.38
DE:UTH Q4 2018 Revenue Results
- Actual Revenue
- EUR 341.01M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2018
- Date
- 02/27/2019
- Time
- Before Open
- Conference Call
- Wednesday, February 27, 2019
Q4 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 5.37- | 6.4 | ― | |
| Aug 05, 2026 | 2026 (Q2) | 6.146.50 | 5.73 | 13.42% (+0.77) | |
| May 06, 2026 | 2026 (Q1) | 6.265.20 | 5.93 | -12.22% (-0.72) | |
| Feb 25, 2026 | 2025 (Q4) | 6.386.88 | 5.53 | 24.39% (+1.35) | |
| Oct 29, 2025 | 2025 (Q3) | 6.546.40 | 5.71 | 12.05% (+0.69) | |
| Jul 30, 2025 | 2025 (Q2) | 6.525.73 | 5.23 | 9.57% (+0.50) | |
| Apr 30, 2025 | 2025 (Q1) | 5.995.93 | 5.52 | 7.46% (+0.41) | |
| Feb 26, 2025 | 2024 (Q4) | 5.725.53 | 3.9 | 41.97% (+1.64) | |
| Oct 30, 2024 | 2024 (Q3) | 5.835.71 | 4.81 | 18.77% (+0.90) | |
| Jul 31, 2024 | 2024 (Q2) | 5.825.23 | 4.69 | 11.64% (+0.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
